semaglutide
Is Bimagrumab Plus Semaglutide Obesity Treatment Cost‑Effective?
In 2024, U.S. obesity-related health expenditures topped $200 billion, according to IQVIA. Combining bimagrumab with semaglutide has not yet demonstrated definitive cost-effectiveness, but early phase data suggest a potential value proposition for payers seeking to curb those costs. Medical Disclaimer: This article is for informational purposes only and does